Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins - Test2 - elhamkhani - TriplyDB

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins

http://www.wikidata.org/entity/Q33393637

about

A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G.Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase On the solution conformation and dynamics of the HIV-1 viral infectivity factor Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa.Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.Host restriction factors in retroviral infection: promises in virus-host interaction.Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.Viral factors in non-progression.Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.Animal models in virus research: their utility and limitations.Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.CBFß and HIV Infection.Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.

P2860

Q24656551-085D2F22-B327-480D-BEA3-10D359EDAE58 Q26823568-78B21CD2-5D28-4B26-A549-413FDD5CD3F5 Q28482052-85D3B198-D592-4B10-8489-837538FF03C2 Q30381745-BD97B629-FB89-4713-B1F9-3659E75BF6DD Q33583855-4005C41F-6729-4EC2-B57A-B82583CD495C Q33654949-8F0BA5E7-3C1E-4AE9-86FF-556037968DAF Q33815187-1771E4E6-8393-4DB1-AA38-A9B3F91A13FE Q33826857-88A1C122-A623-4AA3-8DA7-026751C35D76 Q33966666-6AB7F85F-CEA1-4F55-BD88-DD4A8DB99AD8 Q34179686-090633FE-ECAF-4D2D-92FA-9739388356F7 Q34233314-FDE32A8B-3BB0-4953-8631-5666A1D50181 Q34266485-23DA4E8F-2A58-4974-9E25-945DC6522680 Q34412675-E4893D4C-3B33-4484-A3E5-8F7E00BFC86A Q34416665-185F5A67-D49C-4833-AB89-585725E53D35 Q34493717-B743AA89-495C-4244-80A8-F732FF9C82D9 Q34593794-BE463BB3-DF58-4758-96E6-590814F7E6E8 Q34665129-D437AF06-FDFB-43F9-B06A-FBD0F70C4EA7 Q34695564-999E5716-E2F3-4742-95F5-61CFA74423CE Q35113711-44AADD09-3711-4FD3-96EB-EC442DF722BB Q35176322-1E856F74-3076-4F14-B376-FE26A43AF3B7 Q35531709-5979D411-69E4-457F-B637-A95BDDFF88C5 Q35627352-E3DC01B1-1752-41C8-A6C5-751B52798172 Q36548179-0CB566FA-EDE2-4767-88D8-8785672A93A1 Q36698954-E2CC7DF0-70AF-48F6-B94C-EDC5859899A6 Q36871140-103962DE-93A5-4AD6-8DAA-3457EDC6F48D Q37153444-D4343D33-4239-41C1-B648-4C975E1DF8B9 Q37333859-61C0202D-E87D-42B9-80DF-EDC5A9F73288 Q37412098-E00D7F2C-3744-4AF2-AC47-30C2D674CC8C Q37504507-E7540611-AAFB-4FE5-9433-D823C35EC779 Q37599297-FDE8F8E9-8FF1-4716-961B-286BF5A461E9 Q37644056-474EE67E-D653-4F62-80E5-43E12DA39C0B Q38043556-4FAF1BDB-26D4-418C-8846-9C49121C924C Q38125575-061EABDD-2932-49BD-8821-D814988BE81C Q38269459-84454FF0-2411-4DDF-A319-B353FD5AF68D Q38879828-8CC5A0B9-C85F-42A8-9581-E3462EA1D99C Q39181425-777B2FA7-7415-4F2D-89F6-8F7030A9B912 Q41892602-E0DDFA5B-A610-4A40-AED6-0471A6699C98

P2860

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins

http://www.wikidata.org/entity/Q33393637

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@ast

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@en

type

label

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@ast

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@en

prefLabel

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@ast

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@en

P1433

Q33393637-953095B9-9160-4B9C-8239-47BF4703C47A

P1476

Q33393637-C5ADF9B8-2C15-45CD-A889-FCA4A888E775

P2093

Q33393637-00241DE2-ADAF-4336-AC4C-E3641C1FB528

Q33393637-5E660206-9CDB-4589-B708-D8226D5FA95F

Q33393637-8B669689-B566-4839-AE54-AA27C0B828FE

Q33393637-8E7A707B-DB4C-46A1-B646-EC5978451251

Q33393637-FD490CC1-C947-4DBF-8159-7D6C52B240EF

P2860

Q33393637-0C93268E-E092-4830-A988-9DBCFDE36A9B

Q33393637-0F57B665-6F54-4876-AF17-8731F344EA50

Q33393637-123708FE-8C8A-498C-96A8-1D94CBAB423A

Q33393637-17B69DFE-3224-4074-8BBA-4B4C1C61690B

Q33393637-185FE469-219A-4F31-B546-E493213649F1

Q33393637-18E0109E-40A2-468A-A2B9-13D9FCC125D9

Q33393637-19DE3AF8-D1E6-4579-9225-6301FB710343

Q33393637-2657E3D1-A6F1-4EE6-B53D-0ED400E98A7C

Q33393637-27779018-D16A-4C3F-A3E8-A57D21EFE811

Q33393637-2ACD26ED-A4B2-4E8D-9C94-09A5A7670DB7

P304

Q33393637-D937E9DF-2E88-492A-BE17-CD10DDCC9C48

P31

Q33393637-8B18C7DA-8D9C-4780-B5D6-8A552BD8F733

P356

Q33393637-954F1F2E-4331-4B93-8A5F-9EBD38C68D2E

P407

Q33393637-A85312AB-8485-4FAD-B16E-FFDCAE0AB5C4

P433

Q33393637-71ACF196-9645-494D-81EA-F08660BE553C

P478

Q33393637-990F17C3-8B0F-4E2C-854F-4C2E68D4AEF5

P577

Q33393637-B66DD2B3-322B-4CA3-98E3-E9909A89811F

P5875

Q33393637-2504E4B8-21F6-47D2-BD39-15B80F621FC2

P698

Q33393637-AA67FDF8-C319-4F12-A862-3A4250923F4B

P932

Q33393637-77361555-70C9-4496-A330-CBF6C58C4B80

P356

JOURNAL.PONE.0003963

P1433

P1476

Distinct determinants in HIV-1 ...... verse host anti-viral proteins

@en

P2093

Anna Maria Niewiadomska

http://www.w3.org/2001/XMLSchema#string

Gongying Chen

http://www.w3.org/2001/XMLSchema#string

Rongzhen Xu

http://www.w3.org/2001/XMLSchema#string

Wenyan Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Fang Yu

http://www.w3.org/2001/XMLSchema#string

P2860

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1

Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

P304

e3963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003963

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23669737

http://www.w3.org/2001/XMLSchema#string

P698

19088851

http://www.w3.org/2001/XMLSchema#string

P932

2597746

http://www.w3.org/2001/XMLSchema#string